Cargando…
β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury
BACKGROUND: Lung ischemia-reperfusion (I/R) injury is a serious clinical problem without effective treatment. Enhancing branched-chain amino acids (BCAA) metabolism can protect against cardiac I/R injury, which may be related to bioactive molecules generated by BCAA metabolites. L-β-aminoisobutyric...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696792/ https://www.ncbi.nlm.nih.gov/pubmed/38049750 http://dx.doi.org/10.1186/s10020-023-00729-z |
_version_ | 1785154644926791680 |
---|---|
author | Zhang, Ziyue Li, Xingbing Guo, Jingwen He, Bo Wu, Lianpan Yang, Rongpei Li, Xingyue Fang, Dandong Yang, XiaoLi Yang, Donghai Wang, Fengxian Tang, Ming Han, Yu Jose, Pedro A. Wang, Hongyong Zeng, Chunyu |
author_facet | Zhang, Ziyue Li, Xingbing Guo, Jingwen He, Bo Wu, Lianpan Yang, Rongpei Li, Xingyue Fang, Dandong Yang, XiaoLi Yang, Donghai Wang, Fengxian Tang, Ming Han, Yu Jose, Pedro A. Wang, Hongyong Zeng, Chunyu |
author_sort | Zhang, Ziyue |
collection | PubMed |
description | BACKGROUND: Lung ischemia-reperfusion (I/R) injury is a serious clinical problem without effective treatment. Enhancing branched-chain amino acids (BCAA) metabolism can protect against cardiac I/R injury, which may be related to bioactive molecules generated by BCAA metabolites. L-β-aminoisobutyric acid (L-BAIBA), a metabolite of BCAA, has multi-organ protective effects, but whether it protects against lung I/R injury is unclear. METHODS: To assess the protective effect of L-BAIBA against lung I/R injury, an animal model was generated by clamping the hilum of the left lung, followed by releasing the clamp in C57BL/6 mice. Mice with lung I/R injury were pre-treated or post-treated with L-BAIBA (150 mg/kg/day), given by gavage or intraperitoneal injection. Lung injury was assessed by measuring lung edema and analyzing blood gases. Inflammation was assessed by measuring proinflammatory cytokines in bronchoalveolar lavage fluid (BALF), and neutrophil infiltration of the lung was measured by myeloperoxidase activity. Molecular biological methods, including western blot and immunofluorescence, were used to detect potential signaling mechanisms in A549 and BEAS-2B cells. RESULTS: We found that L-BAIBA can protect the lung from I/R injury by inhibiting ferroptosis, which depends on the up-regulation of the expressions of GPX4 and SLC7A11 in C57BL/6 mice. Additionally, we demonstrated that the Nrf-2 signaling pathway is key to the inhibitory effect of L-BAIBA on ferroptosis in A549 and BEAS-2B cells. L-BAIBA can induce the nuclear translocation of Nrf-2. Interfering with the expression of Nrf-2 eliminated the protective effect of L-BAIBA on ferroptosis. A screening of potential signaling pathways revealed that L-BAIBA can increase the phosphorylation of AMPK, and compound C can block the Nrf-2 nuclear translocation induced by L-BAIBA. The presence of compound C also blocked the protective effects of L-BAIBA on lung I/R injury in C57BL/6 mice. CONCLUSIONS: Our study showed that L-BAIBA protects against lung I/R injury via the AMPK/Nrf-2 signaling pathway, which could be a therapeutic target. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00729-z. |
format | Online Article Text |
id | pubmed-10696792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106967922023-12-06 β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury Zhang, Ziyue Li, Xingbing Guo, Jingwen He, Bo Wu, Lianpan Yang, Rongpei Li, Xingyue Fang, Dandong Yang, XiaoLi Yang, Donghai Wang, Fengxian Tang, Ming Han, Yu Jose, Pedro A. Wang, Hongyong Zeng, Chunyu Mol Med Research Article BACKGROUND: Lung ischemia-reperfusion (I/R) injury is a serious clinical problem without effective treatment. Enhancing branched-chain amino acids (BCAA) metabolism can protect against cardiac I/R injury, which may be related to bioactive molecules generated by BCAA metabolites. L-β-aminoisobutyric acid (L-BAIBA), a metabolite of BCAA, has multi-organ protective effects, but whether it protects against lung I/R injury is unclear. METHODS: To assess the protective effect of L-BAIBA against lung I/R injury, an animal model was generated by clamping the hilum of the left lung, followed by releasing the clamp in C57BL/6 mice. Mice with lung I/R injury were pre-treated or post-treated with L-BAIBA (150 mg/kg/day), given by gavage or intraperitoneal injection. Lung injury was assessed by measuring lung edema and analyzing blood gases. Inflammation was assessed by measuring proinflammatory cytokines in bronchoalveolar lavage fluid (BALF), and neutrophil infiltration of the lung was measured by myeloperoxidase activity. Molecular biological methods, including western blot and immunofluorescence, were used to detect potential signaling mechanisms in A549 and BEAS-2B cells. RESULTS: We found that L-BAIBA can protect the lung from I/R injury by inhibiting ferroptosis, which depends on the up-regulation of the expressions of GPX4 and SLC7A11 in C57BL/6 mice. Additionally, we demonstrated that the Nrf-2 signaling pathway is key to the inhibitory effect of L-BAIBA on ferroptosis in A549 and BEAS-2B cells. L-BAIBA can induce the nuclear translocation of Nrf-2. Interfering with the expression of Nrf-2 eliminated the protective effect of L-BAIBA on ferroptosis. A screening of potential signaling pathways revealed that L-BAIBA can increase the phosphorylation of AMPK, and compound C can block the Nrf-2 nuclear translocation induced by L-BAIBA. The presence of compound C also blocked the protective effects of L-BAIBA on lung I/R injury in C57BL/6 mice. CONCLUSIONS: Our study showed that L-BAIBA protects against lung I/R injury via the AMPK/Nrf-2 signaling pathway, which could be a therapeutic target. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00729-z. BioMed Central 2023-12-04 /pmc/articles/PMC10696792/ /pubmed/38049750 http://dx.doi.org/10.1186/s10020-023-00729-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Zhang, Ziyue Li, Xingbing Guo, Jingwen He, Bo Wu, Lianpan Yang, Rongpei Li, Xingyue Fang, Dandong Yang, XiaoLi Yang, Donghai Wang, Fengxian Tang, Ming Han, Yu Jose, Pedro A. Wang, Hongyong Zeng, Chunyu β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title | β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title_full | β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title_fullStr | β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title_full_unstemmed | β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title_short | β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
title_sort | β-aminoisobutyrics acid, a metabolite of bcaa, activates the ampk/nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696792/ https://www.ncbi.nlm.nih.gov/pubmed/38049750 http://dx.doi.org/10.1186/s10020-023-00729-z |
work_keys_str_mv | AT zhangziyue baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT lixingbing baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT guojingwen baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT hebo baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT wulianpan baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT yangrongpei baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT lixingyue baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT fangdandong baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT yangxiaoli baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT yangdonghai baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT wangfengxian baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT tangming baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT hanyu baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT josepedroa baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT wanghongyong baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury AT zengchunyu baminoisobutyricsacidametaboliteofbcaaactivatestheampknrf2pathwaytopreventferroptosisandameliorateslungischemiareperfusioninjury |